Effects of GABA, glycine, acetylcholine, and glutamate (agonists of the GABAa/benzodiazepine, glycine, choline, and glutamate receptors, respectively) at concentrations in the range 10(-8)-10(-4) M on the activity of "basal" Mg(2+)-ATPase of the plasma membrane fraction from bream brain and on its activation by Cl(-) were investigated. GABA and glycine activated "basal" Mg(2+)-ATPase activity and suppressed its activation by Cl(-). Acetylcholine and glutamate activated "basal" Mg(2+)-ATPase to a lesser extent and did not suppress the activation of the enzyme by Cl(-). The activation of "basal" Mg(2+)-ATPase by neuromediators was decreased by blockers of the corresponding receptors (picrotoxin, strychnine, benztropine mesylate, and D-2-amino-5-phosphonovaleric acid). In addition, picrotoxin and strychnine eliminated the inhibiting effect of GABA and glycine, respectively, on the Cl(-)-stimulated Mg(2+)-ATPase activity. Agonists of the GABAa/benzodiazepine receptor--phenazepam (10(-8)-10(-4) M) and pentobarbital (10(-6)-10(-3) M)--activated the "basal" Mg(2+)-ATPase activity and decreased the Cl(-)-stimulated Mg(2+)-ATPase activity. The dependence of both enzyme activities on ligand concentration is bell-shaped. Moreover, phenazepam and pentobarbital increased the "basal" Mg(2+)-ATPase activity in the presence of 10(-7) M GABA and did not influence it in the presence of 10(-4) M GABA and 10(-6) M glycine. The data suggest that in the fish brain membranes the Cl(-)-stimulated Mg(2+)-ATPase interacts with GABAa/benzodiazepine and glycine receptors but not with m-choline and glutamate receptors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.